(Q39748993)

14 September 2017

title

Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells? (English)

1 reference

14 September 2017

1 reference

1 reference

Fang-Zhen Shen

1

1 reference

14 September 2017

Jing Wang

2

1 reference

14 September 2017

Jun Liang

3

1 reference

14 September 2017

Kun Mu

4

1 reference

14 September 2017

Ji-Yuan Hou

5

1 reference

14 September 2017

Yan-Tao Wang

6

1 reference

14 September 2017

publication date

1 February 2010

1 reference

International Journal of Experimental Pathology

14 September 2017

published in

1 reference

14 September 2017

volume

91

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

10-16

1 reference

Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study

14 September 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Molecular reaction mechanisms of combination treatments of low-dose cisplatin with radiotherapy and photodynamic therapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Vascular endothelial growth factor (VEGF) inhibition--a critical review

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Angiogenesis and apoptosis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812723

Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice

30 August 2018

1 reference

12 December 2020

On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A

1 reference

12 December 2020

Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis

1 reference

12 December 2020

[Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]

1 reference

12 December 2020

Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer

1 reference

12 December 2020

Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth

1 reference

12 December 2020

10.1111/J.1365-2613.2009.00684.X

Identifiers

DOI

1 reference

14 September 2017

0 references

1 reference